Oxford Nanopore Technologies plc (LON:ONT)
London · Delayed Price · Currency is GBP · Price in GBX 155.00
-3.00 (-1.90%)
At close: Jan 30, 2026
LON:ONT Revenue
Oxford Nanopore Technologies had revenue of 105.60M GBP in the half year ending June 30, 2025, with 22.79% growth. This brings the company's revenue in the last twelve months to 204.69M, up 22.01% year-over-year. In the year 2024, Oxford Nanopore Technologies had annual revenue of 183.19M with 7.97% growth.
Revenue (ttm)
204.69M
Revenue Growth
+22.01%
P/S Ratio
7.32
Revenue / Employee
154.48K
Employees
1,325
Market Cap
1.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 183.19M | 13.52M | 7.97% |
| Dec 31, 2023 | 169.67M | -28.94M | -14.57% |
| Dec 31, 2022 | 198.60M | 64.94M | 48.59% |
| Dec 31, 2021 | 133.66M | 19.80M | 17.39% |
| Dec 31, 2020 | 113.86M | 61.80M | 118.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genus | 672.80M |
| Oxford Biomedica | 151.21M |
| hVIVO | 54.47M |
| Bioventix | 13.12M |
| Scancell Holdings | 4.71M |
| PureTech Health | 4.66M |
| SkinBioTherapeutics | 4.64M |
| 4basebio | 1.78M |
Oxford Nanopore Technologies News
- 19 days ago - Oxford Nanopore Technologies PLC at JPMorgan Healthcare Conference Transcript - GuruFocus
- 19 days ago - Oxford Nanopore Technologies plc (ONTTF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 20 days ago - Fed concerns weigh on the FTSE 100 - Investomania
- 20 days ago - UK Stock Market News: Oxford Nanopore, SSP, MicroSalt - The Armchair Trader
- 20 days ago - Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe - Business Wire
- 7 weeks ago - UK Stock Market News: Smith & Nephew, Unilever, Oxford Nanopore - The Armchair Trader
- 2 months ago - Oxford Nanopore Technologies PLC at Citi Global Healthcare Conference Transcript - GuruFocus
- 2 months ago - Oxford Nanopore Technologies plc (ONTTF) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha